Search results for "ANTIBIOTICS"

showing 10 items of 472 documents

Epidemiological analysis of Salmonella enterica from beef sampled in the slaughterhouse and retailers in Dakar (Senegal) using pulsed-field gel elect…

2007

Seventy-eight isolates of Salmonella spp. isolated from beef sampled from the official city slaughterhouse and from retailers in Dakar, Senegal were analyzed using serotyping, antimicrobial testing and macrorestriction profiling by Pulsed-Field Gel Electrophoresis (PFGE). These analyses were done to identify clonal relationships and potential transmission routes in beef channel. XbaI macrorestriction allowed defining 17 genotypes among the six main analyzed serotypes: Salmonella bredeney (3 genotypes), S. muenster (6), S. waycross (1), S. corvallis (3), S. kentucky (1) and S. brandenburg (3). The cross analysis of PFGE profiles and origin of the beef samples reveals a wide range of contamin…

SerotypeSalmonellaVeterinary medicineSusceptibility testingMeatGenotypeFood Handlingmedicine.drug_classSalmonella BredeneyAntibioticsColony Count MicrobialFood ContaminationMicrobial Sensitivity Testsmedicine.disease_causeMicrobiologyMicrobiologyAntibiotic resistanceHousefliesDrug Resistance BacterialPrevalencePulsed-field gel electrophoresismedicineAnimalsHumansSerotypingDose-Response Relationship DrugbiologySalmonella entericaHygieneGeneral Medicinebiology.organism_classificationSenegalAnti-Bacterial AgentsElectrophoresis Gel Pulsed-FieldConsumer Product SafetySalmonella entericaFood MicrobiologyCattleAbattoirsFood ScienceInternational Journal of Food Microbiology
researchProduct

Infections caused by Pseudomonas aeruginosa: relatively frequent isolation of serogroup 12 from clinical specimens.

1985

Serological typing of P. aeruginosa is the most simple and reliable procedure recommended for ≪ in-house ≫ investigations and for studies of suspected outbreaks of infection by this microorganism. It is also a useful procedure in order to know serotype prevalence in a definite geografical area and to obtain indications about the more appropriate composition of polivalent anti-Pseudomonas vaccines. In the present report, we describe the relatively high frequency of isolation of serogroup 12 from patients in Palermo, Italy. Serogroup 12 is very rare in north-Europe and in the USA, and, as a consequence, it is not included in some vaccine preparations. In Palermo, strains belonging to this ser…

Serotypemedicine.medical_specialtyIsolation (health care)Pseudomonas VaccinesEpidemiologymedicine.drug_classAntibioticsBurn Unitsmedicine.disease_causeMicrobiologySerologyEpidemiologymedicineHumansSurgical Wound InfectionPseudomonas InfectionsTypingVaccines CombinedSerotypingRespiratory Tract InfectionsPseudomonas aeruginosabusiness.industryOutbreakVirologyItalyBacterial VaccinesPseudomonas aeruginosaUrinary Tract InfectionsbusinessBurnsEuropean journal of epidemiology
researchProduct

Anidulafungin in combination with amphotericin B against Aspergillus fumigatus.

2009

ABSTRACT We investigated the effects of anidulafungin alone and in combination with amphotericin B against Aspergillus fumigatus . Indifference was the only type of interaction observed in vitro. Anidulafungin at 1 and 5 mg/kg of body weight/day, amphotericin B at 1 mg/kg/day, and combination therapy prolonged the survival of mice with invasive aspergillosis. Anidulafungin at 5 mg/kg/day, alone and in combination with amphotericin B, reduced the kidney fungal burden. Overall, the combination was not superior to the most active single drug.

Settore MED/07 - Microbiologia E Microbiologia ClinicaAntifungal AgentsCombination therapymedicine.drug_classAntibioticsMicrobial Sensitivity TestsPharmacologyAspergillosisAnidulafunginKidneyAspergillus fumigatusMicrobiologyEchinocandinsMicePharmacotherapyAmphotericin BAmphotericin BmedicineAnimalsAspergillosisPharmacology (medical)Experimental TherapeuticsPharmacologyAspergillusbiologyAspergillus fumigatusaspergillus anidulafungin amphotericin BBrainbiology.organism_classificationmedicine.diseasebacterial infections and mycosesInfectious DiseasesAnidulafunginDrug Therapy Combinationmedicine.drugAntimicrobial agents and chemotherapy
researchProduct

Pyrocoll, an Antibiotic, Antiparasitic and Antitumor Compound Produced by a Novel Alkaliphilic Streptomyces Strain

2003

A new secondary metabolite was detected in the culture extract of Streptomyces sp. AK 409 by HPLC-diode-array screening. The metabolite was identified as pyrocoll, which is known to be a constituent of cigarette smoke. Pyrocoll is known as a synthetic compound, but until now had not been isolated as a natural product from a microorganism. The compound showed biological activity against various Arthrobacter strains, filamentous fungi, several pathogenic protozoa, and some human tumor cell lines.

Spectrophotometry InfraredAntiparasiticmedicine.drug_classMetaboliteAntiprotozoal AgentsMicrobial Sensitivity TestsSecondary metaboliteStreptomycesMass SpectrometryMicrobiologyMicechemistry.chemical_compoundArthrobacterDrug DiscoverymedicineAnimalsHumansPyrrolesNuclear Magnetic Resonance BiomolecularChromatography High Pressure LiquidSoil MicrobiologyAntibacterial agentPharmacologyAntibiotics AntineoplasticbiologyStreptomycetaceaebiology.organism_classificationStreptomyceschemistryFermentationChromatography GelActinomycetalesDrug Screening Assays AntitumorHeLa Cellsmedicine.drugThe Journal of Antibiotics
researchProduct

Polyester vascular prostheses coated with a cyclodextrin polymer and activated with antibiotics: Cytotoxicity and microbiological evaluation

2008

Abstract Polyester (PET) vascular grafts are used to replace or bypass damaged arteries. To minimize the risk of infection during and after surgical interventions, a PET vascular prosthesis (Polythese®) was functionalized with cyclodextrin polymers (PolyCDs) in order to obtain the controlled release of antibiotics (ABs: ciprofloxacin, vancomcyin and rifampicin). An epithelial cell line (L132) was used to determine the viability of the antibiotics, and human pulmonary microvascular endothelial cells (HPMEC) were used for cell proliferation by cell counting and cell vitality with Alamar Blue fluorescent dye. Staphylococcus aureus, Escherichia coli and Enteroccocus sp. were used to determine t…

Staphylococcus aureusMaterials scienceCell Survivalmedicine.drug_classPolyestersAntibioticsBiomedical EngineeringMicrobial Sensitivity TestsProsthesis DesignBiochemistryMicrobiologyBiomaterialsMinimum inhibitory concentrationCiprofloxacinVancomycinIn vivoEscherichia colimedicineHumansCelluloseCytotoxicityMolecular BiologyCyclodextrinsGeneral MedicineAntimicrobialAnti-Bacterial AgentsBlood Vessel ProsthesisCiprofloxacinSpectrophotometryToxicityVancomycinRifampinEnterococcusBiotechnologymedicine.drugActa Biomaterialia
researchProduct

Pyrrolomycins as potential anti-staphylococcal biofilms agents

2010

With the goal of discovering new anti-infective agents active against microbial biofilms, this investigation focused on some natural pyrrolomycins, a family of halogenated pyrrole antibiotics. In this study the anti-staphylococcal biofilm activity of pyrrolomycins C, D, F1, F2a, F2b, F3 and of the synthesized related compounds I, II, III were investigated. The susceptibility of six staphylococcal biofilms was determined by methyltiazotetrazolium staining. Most of the compounds were active at concentrations of 1.5 microg ml(-1) with significant inhibition percentages. A few of the compounds were active at the lowest screening concentration of 0.045 microg ml(-1). The population log reduction…

Staphylococcus aureusSynthetic derivativesmedicine.drug_classCell SurvivalAntibioticsPopulationMicrobial Sensitivity TestsAquatic ScienceBiologymedicine.disease_causeSettore BIO/19 - Microbiologia GeneraleApplied Microbiology and BiotechnologyPolymerase Chain ReactionBacterial AdhesionMicrobiologyCell LineInhibitory Concentration 50medicineStaphylococcus epidermidisHumansPyrroleseducationWater Science and TechnologyMicrobial BiofilmsCell Proliferationeducation.field_of_studyMolecular StructureBiofilmStainingAnti-Bacterial AgentsStaphylococcal biofilms Anti-biofilm agents PyrrolomycinsStaphylococcus aureusBiofilmsToxicity
researchProduct

Antibacterial Activity of Desert Truffles from Saudi Arabia Against Staphylococcus aureus and Pseudomonas aeruginosa

2017

Abstract Medicinal mushrooms represent an unlimited source of polysaccharides with nutritional, antitumoral, antibacterial, and immune-stimulating properties. Traditional studies of epigeous higher Basidiomycetes have recently been joined by studies of hypogeous fungi and, in particular, of so-called desert truffles. With the aim to obtain novel agents against bacteria of clinical importance, we focused on the edible desert truffle mushrooms Tirmania pinoyi, Terfezia claveryi, and Picoa juniperi as sources of new antimicrobial agents. In particular, we investigated the in vitro antibacterial activity of acid-soluble protein extracts (aqueous extracts) of these 3 species against the Gram-pos…

Staphylococcus aureusmedicine.drug_classAntibioticsSaudi ArabiaHuman pathogenMicrobial Sensitivity TestsBiologymedicine.disease_causeApplied Microbiology and BiotechnologyMicrobiology0404 agricultural biotechnologyAscomycotaDrug DiscoverymedicinePharmacologyTrufflePseudomonas aeruginosa04 agricultural and veterinary sciencesAntimicrobialbiology.organism_classification040401 food scienceAnti-Bacterial AgentsStaphylococcus aureusPseudomonas aeruginosaantibacterial activity Basidiomycetes desert truffle human pathogens medicinal mushrooms Picoa juniperi Terfezia claveryi Tirmania pinoyiSettore BIO/03 - Botanica Ambientale E ApplicataAntibacterial activityBacteria
researchProduct

Asymmetric Disulfanylbenzamides as Irreversible and Selective Inhibitors of Staphylococcus aureus Sortase A

2020

Abstract Staphylococcus aureus is one of the most frequent causes of nosocomial and community‐acquired infections, with drug‐resistant strains being responsible for tens of thousands of deaths per year. S. aureus sortase A inhibitors are designed to interfere with virulence determinants. We have identified disulfanylbenzamides as a new class of potent inhibitors against sortase A that act by covalent modification of the active‐site cysteine. A broad series of derivatives were synthesized to derive structure‐activity relationships (SAR). In vitro and in silico methods allowed the experimentally observed binding affinities and selectivities to be rationalized. The most active compounds were f…

Staphylococcus aureusmedicine.drug_classdrug designAntibioticsVirulenceMicrobial Sensitivity Testsmedicine.disease_cause01 natural sciencesBiochemistrybiofilmMicrobiology570 Life sciencesStructure-Activity RelationshipBacterial ProteinsAntibioticssortase ADrug DiscoverymedicineGeneral Pharmacology Toxicology and PharmaceuticsEnzyme InhibitorsCytotoxicityPharmacologyFull PaperDose-Response Relationship DrugMolecular Structure010405 organic chemistryChemistryOrganic ChemistryBiofilmFull PapersAminoacyltransferasesIn vitro0104 chemical sciencesAnti-Bacterial Agents010404 medicinal & biomolecular chemistryCysteine EndopeptidasesStaphylococcus aureusSortase Addc:540BenzamidesMolecular MedicineCysteine570 BiowissenschaftenChemmedchem
researchProduct

A Silicone Ventricular Catheter Coated with a Combination of Rifampin and Trimethoprim for the Prevention of Catheter-related Infections

1998

So-called antiinfective catheters which are generated by incorporation of antimicrobial substances into polymers appear to be effectful devices in the prevention of catheter related infections. Such devices mainly act by prevention of bacterial colonization of the catheter surface rather than by inhibition of adherence. In a preceding study, we developed a rifampin-containing silicone catheter for the prevention of ventricular shunt infection. In the present study, this work was continued with a combination of antimicrobials incorporated in silicone ventricular catheters to reduce the risk of rifampin resistance and to expand the antimicrobial spectrum. We found that the drug release kineti…

Staphylococcus aureusmedicine.medical_specialtymedicine.drug_classImmunologyAntibioticsColony Count Microbialmedicine.disease_causeBacterial AdhesionTrimethoprimchemistry.chemical_compoundCatheters IndwellingSiliconemedicineAntibacterial agentbusiness.industryAntimicrobialTrimethoprimAnti-Bacterial AgentsSurgeryCatheterchemistryStaphylococcus aureusRifampinbusinessRifampicinmedicine.drugZentralblatt für Bakteriologie
researchProduct

Draft Genome Sequence of the Microbispora sp. Strain ATCC-PTA-5024, Producing the Lantibiotic NAI-107.

2014

ABSTRACT We report the draft genome sequence of Microbispora sp. strain ATCC-PTA-5024, a soil isolate that produces NAI-107, a new lantibiotic with the potential to treat life-threatening infections caused by multidrug-resistant Gram-positive pathogens. The draft genome of strain Microbispora sp. ATCC-PTA-5024 consists of 8,543,819 bp, with a 71.2% G+C content and 7,860 protein-coding genes.

Strain atccWhole genome sequencingStrain (chemistry)Microbispora sp.GeneticsProkaryotesLantibioticsBiologyMolecular BiologyGenomeGeneC contentMicrobiologyGenome announcements
researchProduct